CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a Position Paper from the Fleischner society

Lancet Respiratory Medicine,The - Tập 3 Số 6 - Trang 483-496 - 2015
David M. Hansell1, Jonathan Goldin2, Talmadge E. King3, David A. Lynch4, Luca Richeldi5, Athol U. Wells6
1Department of Radiology, Royal Brompton and Harefield National Health Service Foundation Trust, London, UK
2Radiological Sciences, UCLA Medical Center, Los Angeles, CA, USA.
3University of California San Francisco, CA. USA
4National Department of Radiology, Jewish Medical and Research Center, Denver, CO, USA
5Department of Respiratory Medicine, University of Southampton, Southampton, UK.
6Interstitial Lung Disease Unit, Royal Brompton and Harefield National Health Service Foundation Trust, London, UK.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Richeldi, 2014, Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis, N Engl J Med, 370, 2071, 10.1056/NEJMoa1402584

King, 2014, A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis, N Engl J Med, 370, 2083, 10.1056/NEJMoa1402582

Wells, 2014, Treatment strategies for idiopathic interstitial pneumonias, Curr Opin Pulm Med, 20, 442, 10.1097/MCP.0000000000000085

Goh, 2008, Interstitial lung disease in systemic sclerosis: a simple staging system, Am J Respir Crit Care Med, 177, 1248, 10.1164/rccm.200706-877OC

Ley, 2012, A multidimensional index and staging system for idiopathic pulmonary fibrosis, Ann Intern Med, 156, 684, 10.7326/0003-4819-156-10-201205150-00004

Ryerson, 2014, Predicting survival across chronic interstitial lung disease: the ILD-GAP model, Chest, 145, 723, 10.1378/chest.13-1474

Best, 2008, Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality, Radiology, 246, 935, 10.1148/radiol.2463062200

Goldin, 2013, Computed tomography as a biomarker in clinical trials imaging, J Thorac Imaging, 28, 291, 10.1097/RTI.0b013e3182a1d93d

Saketkoo, 2014, Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials, Thorax, 69, 428, 10.1136/thoraxjnl-2013-204202

Ryerson, 2013, Prevalence and prognosis of unclassifiable interstitial lung disease, Eur Respir J, 42, 750, 10.1183/09031936.00131912

Schmidt, 2014, Predicting pulmonary fibrosis disease course from past trends in pulmonary function, Chest, 145, 579, 10.1378/chest.13-0844

Travis, 2013, An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, Am J Respir Crit Care Med, 188, 733, 10.1164/rccm.201308-1483ST

Latsi, 2003, Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends, Am J Respir Crit Care Med, 168, 531, 10.1164/rccm.200210-1245OC

Peelen, 2010, Fibrotic idiopathic interstitial pneumonias: mortality is linked to a decline in gas transfer, Respirology, 15, 1233, 10.1111/j.1440-1843.2010.01862.x

Wells, 2003, Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography, Am J Respir Crit Care Med, 167, 962, 10.1164/rccm.2111053

King, 2001, Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model, Am J Respir Crit Care Med, 164, 1171, 10.1164/ajrccm.164.7.2003140

Flaherty, 2006, Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test, Am J Respir Crit Care Med, 174, 803, 10.1164/rccm.200604-488OC

Eaton, 2005, Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia, Am J Respir Crit Care Med, 171, 1150, 10.1164/rccm.200405-578OC

du Bois, 2011, Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference, Am J Respir Crit Care Med, 183, 1231, 10.1164/rccm.201007-1179OC

Raghu, 2011, An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, Am J Respir Crit Care Med, 183, 788, 10.1164/rccm.2009-040GL

Wells, 2013, Forced vital capacity as a primary end point in idiopathic pulmonary fibrosis treatment trials: making a silk purse from a sow's ear, Thorax, 68, 309, 10.1136/thoraxjnl-2012-202640

Austin, 1996, Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society, Radiology, 200, 327, 10.1148/radiology.200.2.8685321

Hansell, 2008, Fleischner Society: glossary of terms for thoracic imaging, Radiology, 246, 697, 10.1148/radiol.2462070712

Watadani, 2013, Interobserver variability in the CT assessment of honeycombing in the lungs, Radiology, 266, 936, 10.1148/radiol.12112516

Lynch, 2005, High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis, Am J Respir Crit Care Med, 172, 488, 10.1164/rccm.200412-1756OC

Walsh, 2014, Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants, Thorax, 69, 216, 10.1136/thoraxjnl-2013-203843

Edey, 2011, Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality, Eur Radiol, 21, 1586, 10.1007/s00330-011-2098-2

Sumikawa, 2008, Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival, Am J Respir Crit Care Med, 177, 433, 10.1164/rccm.200611-1696OC

Kazerooni, 1997, Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring, AJR Am J Roentgenol, 169, 977, 10.2214/ajr.169.4.9308447

Sundaram, 2008, Reader accuracy and confidence in diagnosing diffuse lung disease on high-resolution computed tomography of the lungs: impact of sampling frequency, Acta Radiol, 49, 870, 10.1080/02841850802227147

Winklehner, 2012, Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices, Ann Rheum Dis, 71, 549, 10.1136/annrheumdis-2011-200564

Sverzellati, 2011, Method for minimizing observer variation for the quantitation of high-resolution computed tomographic signs of lung disease, J Comput Assist Tomogr, 35, 596, 10.1097/RCT.0b013e3182277d05

Silva, 2008, Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time, Radiology, 247, 251, 10.1148/radiol.2471070369

Akira, 1993, Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT, Radiology, 189, 687, 10.1148/radiology.189.3.8080483

Jeong, 2005, Usual interstitial pneumonia and non-specific interstitial pneumonia: serial thin-section CT findings correlated with pulmonary function, Korean J Radiol, 6, 143, 10.3348/kjr.2005.6.3.143

Iwasawa, 2014, CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis, Eur J Radiol, 83, 32, 10.1016/j.ejrad.2012.02.014

Collard, 2007, Acute exacerbations of idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 176, 636, 10.1164/rccm.200703-463PP

Kim, 2001, Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation, J Comput Assist Tomogr, 25, 757, 10.1097/00004728-200109000-00015

Demedts, 2005, High-dose acetylcysteine in idiopathic pulmonary fibrosis, N Engl J Med, 353, 2229, 10.1056/NEJMoa042976

Lloyd, 2011, High-resolution CT of complications of idiopathic fibrotic lung disease, Br J Radiol, 84, 581, 10.1259/bjr/65090500

Martinez, 2005, The clinical course of patients with idiopathic pulmonary fibrosis, Ann Intern Med, 142, 963, 10.7326/0003-4819-142-12_Part_1-200506210-00005

Hartley, 1994, High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease, J Appl Physiol (1985), 76, 271, 10.1152/jappl.1994.76.1.271

Best, 2003, Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment, Radiology, 228, 407, 10.1148/radiol.2282020274

Sverzellati, 2007, Visual score and quantitative CT indices in pulmonary fibrosis: Relationship with physiologic impairment, Radiol Med (Torino), 112, 1160, 10.1007/s11547-007-0213-x

Iwasawa, 2009, Assessment of prognosis of patients with idiopathic pulmonary fibrosis by computer-aided analysis of CT images, J Thorac Imaging, 24, 216, 10.1097/RTI.0b013e3181a6527d

Maldonado, 2014, Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis, Eur Respir J, 43, 204, 10.1183/09031936.00071812

Zavaletta, 2007, High resolution multidetector CT-aided tissue analysis and quantification of lung fibrosis, Acad Radiol, 14, 772, 10.1016/j.acra.2007.03.009

Uppaluri, 1999, Computer recognition of regional lung disease patterns, Am J Respir Crit Care Med, 160, 648, 10.1164/ajrccm.160.2.9804094

Kim, 2008, Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study, Acad Radiol, 15, 1004, 10.1016/j.acra.2008.03.011

Kim, 2011, Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide, Eur Radiol, 21, 2455, 10.1007/s00330-011-2223-2

Coxson, 2013, Sources of variation in quantitative computed tomography of the lung, J Thorac Imaging, 28, 272, 10.1097/RTI.0b013e31829efbe9

Van Dyk, 1982, Lung density as measured by computerized tomography: implications for radiotherapy, Int J Radiat Oncol Biol Phys, 8, 1363, 10.1016/0360-3016(82)90587-9

Wegener, 1978, Measurement of lung density by computed tomography, J Comput Assist Tomogr, 2, 263, 10.1097/00004728-197807000-00003

Lamers, 1998, Reproducibility of spirometrically controlled CT lung densitometry in a clinical setting, Eur Respir J, 11, 942, 10.1183/09031936.98.11040942

Robinson, 1979, Pulmonary tissue attenuation with computed tomography: comparison of inspiration and expiration scans, J Comput Assist Tomogr, 3, 740, 10.1097/00004728-197903060-00006

Kemerink, 1996, Density resolution in quantitative computed tomography of foam and lung, Med Phys, 23, 1697, 10.1118/1.597757

Kemerink, 1997, CT lung densitometry: dependence of CT number histograms on sample volume and consequences for scan protocol comparability, J Comput Assist Tomogr, 21, 948, 10.1097/00004728-199711000-00018

Stoel, 2004, Comparison of the sensitivities of 5 different computed tomography scanners for the assessment of the progression of pulmonary emphysema: a phantom study, Invest Radiol, 39, 1, 10.1097/01.rli.0000091842.82062.a3

1997, Council Directive 97/43/Euratom of 30 June 1997 on health protection of individuals against the dangers of ionizing radiation in relation to medical exposure, and repealing Directive 84/466/Euratom, Off J Eur Communities, L180, 22

Naidich, 1990, Low-dose CT of the lungs: preliminary observations, Radiology, 175, 729, 10.1148/radiology.175.3.2343122

Zwirewich, 1991, Low-dose high-resolution CT of lung parenchyma, Radiology, 180, 413, 10.1148/radiology.180.2.2068303

Sverzellati, 2005, Evaluation of quantitative CT indexes in idiopathic interstitial pneumonitis using a low-dose technique, Eur J Radiol, 56, 370, 10.1016/j.ejrad.2005.05.012

Sverzellati, 2011, Interstitial lung diseases in a lung cancer screening trial, Eur Respir J, 38, 392, 10.1183/09031936.00201809

Bankier, 2010, Dose reduction strategies for thoracic multidetector computed tomography: background, current issues, and recommendations, J Thorac Imaging, 25, 278, 10.1097/RTI.0b013e3181eebc49

Baumueller, 2012, Low-dose CT of the lung: potential value of iterative reconstructions, Eur Radiol, 22, 2597, 10.1007/s00330-012-2524-0

Erbes, 1997, Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?, Chest, 111, 51, 10.1378/chest.111.1.51

Ley, 2011, Clinical course and prediction of survival in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 183, 431, 10.1164/rccm.201006-0894CI

Lederer, 2006, Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 174, 659, 10.1164/rccm.200604-520OC

Peljto, 2013, Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis, JAMA, 309, 2232, 10.1001/jama.2013.5827

Molyneaux, 2014, The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 190, 906, 10.1164/rccm.201403-0541OC

Han, 2008, Sex differences in physiological progression of idiopathic pulmonary fibrosis, Eur Respir J, 31, 1183, 10.1183/09031936.00165207

Lettieri, 2006, Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis, Chest, 129, 746, 10.1378/chest.129.3.746

King, 2001, Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality, Am J Respir Crit Care Med, 164, 1025, 10.1164/ajrccm.164.6.2001056

Nicholson, 2002, The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 166, 173, 10.1164/rccm.2109039

Gay, 1998, Idiopathic pulmonary fibrosis: predicting response to therapy and survival, Am J Respir Crit Care Med, 157, 1063, 10.1164/ajrccm.157.4.9703022

Mura, 2012, Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study, Eur Respir J, 40, 101, 10.1183/09031936.00106011

du Bois, 2011, Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 184, 459, 10.1164/rccm.201011-1790OC

Miller, 2005, Standardisation of spirometry, Eur Respir J, 26, 319, 10.1183/09031936.05.00034805

Gruden, 2013, UIP diagnosed at surgical lung biopsy, 2000-2009: HRCT patterns and proposed classification system, AJR Am J Roentgenol, 200, W458, 10.2214/AJR.12.9437

Chung, 2015, CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis, Chest, 147, 450, 10.1378/chest.14-0976

Noble, 2011, Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials, Lancet, 377, 1760, 10.1016/S0140-6736(11)60405-4

Tashkin, 2006, Cyclophosphamide versus placebo in scleroderma lung disease, N Engl J Med, 354, 2655, 10.1056/NEJMoa055120

Griffiths, 2002, Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function, J Rheumatol, 29, 2371

Giacomelli, 2002, Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis, J Rheumatol, 29, 731

Goldin, 2009, Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study, Chest, 136, 1333, 10.1378/chest.09-0108

Ingegnoli, 2012, Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature, Autoimmun Rev, 11, 335, 10.1016/j.autrev.2011.09.007

Park, 2007, Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes, Am J Respir Crit Care Med, 175, 705, 10.1164/rccm.200607-912OC

Flaherty, 2003, Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease, Am J Respir Crit Care Med, 167, 1410, 10.1164/rccm.200204-373OC

Kocheril, 2005, Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia, Arthritis Rheum, 53, 549, 10.1002/art.21322

Khanna, 2005, Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study, Arthritis Rheum, 52, 592, 10.1002/art.20787

Hant, 2009, Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma, J Rheumatol, 36, 773, 10.3899/jrheum.080633

Sato, 2000, Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis, Dermatology, 200, 196, 10.1159/000018382

Kim, 2010, Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease, Eur Respir J, 35, 1322, 10.1183/09031936.00092309

Song, 2009, Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia, Chest, 136, 23, 10.1378/chest.08-2572

Walsh, 2012, Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants, Eur Radiol, 22, 1672, 10.1007/s00330-012-2427-0

Khanna, 2010, Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials, Clin Exp Rheumatol, 28, S55

Baughman, 2009, Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation, Chest, 136, 526, 10.1378/chest.08-1876

Gibson, 1996, British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment, Thorax, 51, 238, 10.1136/thx.51.3.238

Muers, 1997, A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of long-term corticosteroid treatment, Sarcoidosis Vasc Diffuse Lung Dis, 14, 46

Abehsera, 2000, Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function, AJR Am J Roentgenol, 174, 1751, 10.2214/ajr.174.6.1741751

Akira, 2005, Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis, Chest, 127, 185, 10.1378/chest.127.1.185

Zappala, 2014, Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data, Chest, 145, 101, 10.1378/chest.12-2479

Drent, 2003, Sarcoidosis: assessment of disease severity using HRCT, Eur Radiol, 13, 2462, 10.1007/s00330-003-1965-x

Remy-Jardin, 1994, Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment, Radiology, 191, 675, 10.1148/radiology.191.3.8184045

Leung, 1998, Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay, J Comput Assist Tomogr, 22, 229, 10.1097/00004728-199803000-00013

Bartz, 2000, Airways obstruction in patients with sarcoidosis: expiratory CT scan findings, J Thorac Imaging, 15, 285, 10.1097/00005382-200010000-00009

Davies, 2000, Air trapping in sarcoidosis on computed tomography: correlation with lung function, Clin Radiol, 55, 217, 10.1053/crad.1999.0366

Walsh, 2014, An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study, Lancet Respir Med, 2, 123, 10.1016/S2213-2600(13)70276-5

Chung, 2013, Proton MRI in the evaluation of pulmonary sarcoidosis: comparison to chest CT, Eur J Radiol, 82, 2378, 10.1016/j.ejrad.2013.08.019

Sobic-Saranovic, 2012, The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis, J Nucl Med, 53, 1543, 10.2967/jnumed.112.104380

Mostard, 2012, A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis, BMC Pulm Med, 12, 57, 10.1186/1471-2466-12-57

Mostard, 2013, Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis, Respir Med, 107, 439, 10.1016/j.rmed.2012.11.011

Teirstein, 2007, Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis, Chest, 132, 1949, 10.1378/chest.07-1178

Treglia, 2011, Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review, Sarcoidosis Vasc Diffuse Lung Dis, 28, 87

Umeda, 2011, Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis, Respirology, 16, 713, 10.1111/j.1440-1843.2011.01966.x

Churg, 2009, Pathologic patterns and survival in chronic hypersensitivity pneumonitis, Am J Surg Pathol, 33, 1765, 10.1097/PAS.0b013e3181bb2538

Ohtani, 2005, Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias, Thorax, 60, 665, 10.1136/thx.2004.027326

Sahin, 2007, Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival, Radiology, 244, 591, 10.1148/radiol.2442060640

Vourlekis, 2004, The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis, Am J Med, 116, 662, 10.1016/j.amjmed.2003.12.030

Hanak, 2008, High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis, Chest, 134, 133, 10.1378/chest.07-3005